A phase II clinical trial to evaluate the safety and efficacy of sirolimus for secondary treatment of chronic graft-versus-host disease.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Sirolimus (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 20 Jun 2017 Biomarkers information updated
- 13 Mar 2012 Actual patient number is 44 according to ClinicalTrials.gov.
- 13 Mar 2012 Actual end date changed from Jun 2010 to Jul 2009 as reported by ClinicalTrials.gov.